Activated Pi3k-delta Syndrome
📧 Sign up to get email alerts when something new happens for Activated Pi3k-delta Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Novel Genetic Disorders of the Immune System
NIAID is conducting a clinical trial investigating novel genetic immune disorders, including PI3KCD, CTLA4, STAT3GOF, and MAGT1 deficiencies…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: New Biomarker-based Strategy to Screen and Monitor for Activated Phosphoinositide 3-kinase δ Syndrome
A clinical trial is investigating a biomarker-based strategy to screen and monitor Activated PI3K delta syndrome, and the study is currently…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Pediatric Patients Aged 4 to 11 Years With APDS [Phase 3]
Phase 3 clinical trial evaluating a therapy for Activated PI3K-delta syndrome in pediatric patients aged 4 to 11 is currently active but not…
-
CLINICAL_TRIALS research · 2025-10-28Clinical Trial Update: Pediatric Patients Aged 1 to 6 Years With APDS [Phase 3]
Phase 3 clinical trial evaluating a treatment for Activated PI3K-delta syndrome in pediatric patients aged 1 to 6 years is currently active …